Iridex (IRIX) Net Income Growth (3y) (2014 - 2026)
Iridex (IRIX) Net Income Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.36 Bn | 175.06 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 128.86 Bn | 125.99 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 108.02 Bn | 98.80 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 68.21 Bn | 66.76 Bn | 3.61 Bn | 62.29% |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 60.12% |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | 2.38% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 24.11 Bn | 20.99 Bn | 2.07 Bn | 280.49% |
| 10 | Iridex | 15.36 Mn | 10.77 Mn | 4.74 Mn | 36.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 36.94% |
| Jan 3, 2026 | -26.59% |
| Sep 27, 2025 | 3.80% |
| Jun 28, 2025 | 23.74% |
| Mar 29, 2025 | 10.99% |
| Dec 28, 2024 | -42.58% |
| Sep 28, 2024 | 3.71% |
| Jun 29, 2024 | -57.72% |
| Mar 30, 2024 | -19.89% |
| Sep 30, 2023 | -0.67% |
| Jul 1, 2023 | 0.17% |
| Apr 1, 2023 | -8.18% |
| Dec 31, 2022 | 82.69% |
| Oct 1, 2022 | 0.34% |
| Jul 2, 2022 | 2.52% |
| Apr 2, 2022 | 7.77% |
| Jan 1, 2022 | -54.49% |
| Oct 2, 2021 | 11.03% |
| Jul 3, 2021 | 34.34% |
| Apr 3, 2021 | 17.68% |